Invention Publication
- Patent Title: ANTI-TNF ALPHA ANTIBODY FORMULATIONS
-
Application No.: US17820958Application Date: 2022-08-19
-
Publication No.: US20230151086A1Publication Date: 2023-05-18
- Inventor: William J. CALLAHAN , Rahul Rajan KAUSHIK , Joy BRENNAN
- Applicant: Amgen Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61K47/10 ; A61K47/18
Abstract:
Stable adalimumab formulations are disclosed.
Public/Granted literature
- US12247071B2 Anti-TNF alpha antibody formulations Public/Granted day:2025-03-11
Information query
